Transcranial Magnetic Stimulation System - Indianapolis VAMC

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

250-NETWORK CONTRACT OFFICE 10 (36C250)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C25026Q1013

NAICS

334512 - Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use

Classification Code

6515

Additional Details
Set Aside

SBA

Place of Performance

Indianapolis, Indiana, UNITED STATES

SourceSAM
Documents2
The Department of Veterans Affairs, through its 250-Network Contract Office 10, is soliciting quotations for the procurement of a Transcranial Magnetic Stimulation (TMS) System for the Richard L. Roudebush VA Medical Center, located at 1481 W. 10th St., Indianapolis, Indiana. This opportunity is issued as a combined synopsis/solicitation under procurement identifier 36C25026Q1013, in accordance with the Revolutionary FAR Overhaul (RFO) and Federal Acquisition Regulation (FAR) subpart 12.202, utilizing streamlined procedures for commercial products and services. The solicitation is a firm fixed price, Small Business Administration (SBA) set-aside, and is classified under NAICS code 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing), with a Product Service Code of 6515 (Medical and Surgical Instruments, Equipment, and Supplies). The primary objective of this procurement is to acquire one FDA-cleared TMS system specifically indicated for the treatment of Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD). The system will be used to provide evidence-based, non-invasive neurostimulation therapy for patients who have not responded to conventional pharmacologic treatments, thereby improving clinical outcomes for refractory depression and OCD within the veteran population. Key requirements for the TMS system include: - Delivery of pulsed magnetic stimuli to targeted brain regions, following predefined treatment protocols. - Non-invasive operation, requiring no anesthesia and preserving normal cognitive function. - A flat purchase model with no pay-per-use fees; all treatment protocols must be included in the acquisition. - Upgradeable treatment protocols to accommodate future clinical advancements. - High patient throughput capability, supported by a liquid-cooled TMS coil for sustained use and minimal downtime. - Low acoustic noise operation to enhance patient comfort during treatment. - Adaptability for installation in various clinical settings, regardless of practice size. - Availability of Theraburst stimulation as a therapy option. - Demonstrated clinical safety and efficacy, with the system being free from common antidepressant side effects such as weight gain and sexual dysfunction. - Provision of onsite installation and hands-on orientation for clinical staff. - Inclusion of ongoing technical and marketing support. - Delivery of comprehensive product documentation, warranty information, and support contacts. The contractor is required to be an Original Equipment Manufacturer (OEM) authorized dealer, distributor, or reseller, ensuring that all OEM warranties and services are maintained. Only new equipment will be accepted; remanufactured, used, or "gray market" items are strictly prohibited. All items must be covered by the manufacturer's warranty in accordance with OEM terms and conditions. Interested small business offerors must submit a complete quotation by September 17, 2026, at 12:00pm EST to Rachel MacRae, Contracting Specialist, via email at [email protected]. No telephone inquiries will be accepted. Quotations must include the solicitation number, offeror’s contact information, Unique Entity Identifier (UEI), technical description of the proposed system, completed Buy American Certificate (FAR 52.225-2), and confirmation of current SAM registration. Offerors must also provide an authorized distribution letter and a statement regarding acceptance of the solicitation’s terms and conditions. Award will be made based on a comparative evaluation of quotes in accordance with the Simplified Acquisition Procedures of RFO FAR 12, with the Contracting Officer selecting the quote most favorable to the Government. This procurement represents a significant opportunity for qualified small businesses specializing in advanced medical devices to support the Department of Veterans Affairs’ mission to deliver innovative, effective mental health treatments to veterans in need.